TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

69 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Asthma

    A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

    Testing how well different doses of povorcitinib work and are safe for adults with moderate to

    📍 Allervie Clinical Research · Birmingham, AL · +25 more US sites · Get directions →

    This study tests how well different doses of povorcitinib work and whether it is safe for people with asthma that is not well controlled. People must have moderate to severe asthma despite using inhaled steroid and a long-acting beta-agonist (ICS-LABA) for at least 12 months.

    ✓ Study care freePhase 2Learn more →
  • Kidney disease

    📍 Mayo Clinic in Arizona · Scottsdale, AZ · +4 more US sites · Get directions →

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional anti-cancer drugs, pembrolizumab or trastuzumab deruxtecan(T-DXd) over a range of advanced and/or metastatic solid tumors.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Kidney disease

    Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

    Studying how blood vessel and nerve control during exercise works in people with chronic kidney

    📍 Emory Clinic · Atlanta, GA · +1 more US site · Get directions →

    The goals of this project are to investigate the mechanisms and potential therapies related to exercise capacity in persons with chronic kidney disease (CKD).

    ✓ Study care freePhase 2Ages 40–75Learn more →
  • Asthma

    A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

    Testing different doses of an asthma medicine versus placebo in adults

    📍 AMR Clinical · Tempe, AZ · +16 more US sites · Get directions →

    The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with moderate-to-severe asthma. Study participation will last approximately 65 weeks, including screening, treatment, and follow-up periods.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • High blood pressureKidney disease

    📍 Research Site · Surprise, AZ · +17 more US sites · Get directions →

    International, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Kidney disease

    The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

    Testing a 12-week diabetes medicine combination in kidney transplant patients with kidney disease

    📍 Toronto General Hospital · Toronto, Ontario · Get directions →

    The study aims to determine the short-term efficacy, mechanisms and safety of 12 weeks of dapagliflozin and semaglutide combination therapy in 20 KTR, with and without T2D.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Asthma

    VENTURI (VENTilation Using Respiratory Imaging)

    Testing how two inhaled asthma treatment options affect breathing in people with uncontrolled asthma

    📍 The University of Alabama at Birmingham · Birmingham, AL · Get directions →

    The purpose of the study is to enroll participants with uncontrolled asthma to evaluate the large and small airways and drug delivery utilizing two study drugs: * Beclometasone dipropionate/Formoterol fumarate dihydrate/Glycopyrronium bromide (BDP/FF/G) or Trimbow * Fluticasone furoate/Umeclidinium/Vilanterol (FluF/UMEC/VI ) or Trelegy Ellipta

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Kidney disease

    Acute Equol Supplementation and Vascular Function in Women With and Without CKD

    Testing whether taking equol affects blood vessel function in women with or without CKD

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · Get directions →

    The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk.

    ✓ Study care freePhase 2Ages 50–69WomenLearn more →
  • Asthma

    ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

    Testing a daily medicine for asthma symptoms in adults over 12 weeks

    📍 Enveda Investigative Site · Birmingham, AL · +13 more US sites · Get directions →

    This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants will take oral ENV-294 or placebo once daily for 12 weeks.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Kidney disease

    📍 SouthCoast Research Center, Inc. · Miami, FL · +1 more US site · Get directions →

    The goal of this clinical trial is to learn about the safety (good or bad) of giving two AION-301 intravenous (IV) infusions, in adults with Stage 3 Chronic Kidney Disease (CKD). It will also help to learn if AION-301 reduces the symptoms of CKD and/or progression.

    ✓ Study care freePhase 1Ages 35–75Learn more →
  • Type 2 diabetesHigh blood pressure

    Polypill for Prevention of Cardiomyopathy

    Testing a pill combination to prevent heart muscle disease in people with type 2 diabetes and high

    📍 UT Southwestern Medical Center · Dallas, TX · Get directions →

    This study will investigate the utility of a polypill-based strategy for patients with type 2 diabetes mellitus and high risk of heart failure (HF), as assessed via the WATCH-DM risk score. Polypill therapy will consist of empagliflozin 12.5 mg, losartan 25, 50 or 100 mg, and finerenone 10 mg daily.

    ✓ Study care freePhase 1Ages 18–100Learn more →
  • Kidney disease

    Intradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis.

    Testing whether exercise during dialysis and creatine help people with chronic kidney disease

    📍 IMSS-Bienestar State Haemodialysis Centre · Colima, Coliima · Get directions →

    This study aims to evaluate the effects of creatine monohydrate supplementation and an intradialytic exercise program on body composition, biochemical parameters, and functional capacity in patients with chronic kidney disease (CKD) undergoing maintenance hemodialysis. The study will compare the independent and combined effects of these interventions over an 8-week period to determine their potential benefits in this patient population.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Asthma

    A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

    Testing how safe and effective a study medicine is for moderate to severe asthma

    📍 Velocity Clinical Research, Mobile · Mobile, AL · +35 more US sites · Get directions →

    The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning of people who are affected.

    ✓ Study care freePhase 2Ages 18–70Learn more →
  • Obesity / overweightAsthma

    Metformin IN Asthma for Overweight and Obese Individuals (MINA)

    Testing metformin in overweight or obese adults with asthma that isn’t well controlled

    📍 Johns Hopkins University · Baltimore, MD · +1 more US site · Get directions →

    This is a randomized clinical trial of metformin among overweight or obese adults with not well-controlled asthma despite maintenance inhaler therapy.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Asthma

    A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

    Testing an oral medicine to treat uncontrolled moderate to severe eosinophilic asthma

    📍 Kymera Investigative Site · Lancaster, CA · +26 more US sites · Get directions →

    This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma. The main goals of this study are to investigate how effective KT-621 is at treating uncontrolled moderate to severe eosinophilic asthma, the safety and tolerability of KT-621, and how KT-621 behaves in the body.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Kidney disease

    A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

    Testing safety and effects on urine protein in adults with APOL1 kidney disease

    📍 Research Site · Decatur, AL · +39 more US sites · Get directions →

    This is purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease

    ✓ Study care freePhase 2Ages 18–68Learn more →
  • Kidney disease

    Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine

    Testing colchicine for safety and effects in people with chronic kidney disease

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    This study is designed to determine the efficacy and safety of colchicine in patients with chronic kidney disease.

    ✓ Study care freePhase 2Ages 21–80Learn more →
  • High blood pressureCOPD (chronic lung disease)

    Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

    Testing tadalafil to see if it improves shortness of breath in COPD with high blood pressure in the

    📍 Rocky Mountain Regional VA Medical Center, Aurora, CO · Aurora, CO · +4 more US sites · Get directions →

    The investigators will study whether the drug tadalafil improves shortness of breath in 126 Veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs. The investigators will also assess whether tadalafil improves quality of life, home daily physical activity, exercise endurance, the frequency of acute flares of COPD, blood pressure in the lungs, and lung function.

    ✓ Study care freePhase 2Ages 35–89Learn more →
  • Asthma

    Azithromycin for Critical Asthma - Pediatrics

    Testing azithromycin in children with severe asthma to change the immune response

    📍 Johns Hopkins All Children's Hospital · St. Petersburg, FL · Get directions →

    The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

    ✓ Study care freePhase 2Ages 3–17Learn more →
  • Asthma

    Escitalopram in Asthma Patients With Frequent Exacerbation

    Testing escitalopram to see if it affects asthma flare-ups

    📍 UT Southwestern, 1440 Empire Central, Ste. LD4.100 · Dallas, TX · Get directions →

    Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), such as escitalopram are widely used for mood and anxiety disorders. However, they have also been explored, with promising findings, for a variety of disorders outside of psychiatry.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Kidney disease

    Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

    Testing a GE xenokidney transplant in people with ESRD for safety and effectiveness

    📍 Northwestern Memorial Hospital · Chicago, IL · +1 more US site · Get directions →

    The purpose of this study is to evaluate the safety and efficacy of the 10 GE Xenokidney in patients with ESRD who are either not eligible for conventional allogeneic kidney transplantation (Group 1) or are on an Organ Procurement and Transplantation Network (OPTN) kidney transplant waitlist, but are more likely to die or go untransplanted within 5 years than receive a kidney transplant (Group 2). The study consists of xenotransplantation followed by a 24-week Post-transplant Follow up Period (Part A) to evaluate the efficacy and safety objectives followed by a Long-term Follow-up Period (Part B) to evaluate participant survival, 10 GE Xenokidney survival, and screening for zoonotic infections.

    ✓ Study care freePhase 1Ages 40–70Learn more →
  • Kidney disease

    Bone in CKD Alkali Response (BICARb Pilot Trial)

    Testing whether potassium citrate improves bone health in people with chronic kidney disease

    📍 Albert Einstein College of Medicine · The Bronx, NY · +1 more US site · Get directions →

    The goal of this clinical trial is to test whether potassium citrate improves skeletal health in adults and children with chronic kidney disease. The main questions it aims to answer are: * To evaluate effects of potassium citrate treatment on bone quality and strength.

    ✓ Study care freePhase 2Ages 5–100Learn more →
  • Asthma

    📍 Research Site · Bakersfield, CA · +39 more US sites · Get directions →

    This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Kidney disease

    Testosterone Treatment in Men With Chronic Kidney Disease

    Testing an oral testosterone medicine to raise testosterone in men with chronic kidney disease

    📍 Saint Louis Univeristy · St Louis, MO · Get directions →

    This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).

    ✓ Study care freePhase 2Ages 18–85MenLearn more →
  • Asthma

    Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation

    Testing whether L-citrulline supplements can improve asthma in people after deployment

    📍 National Jewish Health · Denver, CO · Get directions →

    Service men and women returning from deployment are significantly more likely to develop asthma and severe respiratory symptoms from airway obstruction. Why this happens is not well known, but exposure to diesel, burn pits, biomass smoke, and sandstorms are thought to play a role.

    ✓ Study care freePhase 2Ages 18–70Learn more →
  • Asthma

    A Clinical Trial of Soluble Fiber for Asthma

    Testing whether soluble fiber intake affects asthma symptoms

    📍 Phoenix Children's · Phoenix, AZ · Get directions →

    Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake.

    ✓ Study care freePhase 2Ages 6–17Learn more →
  • High blood pressureDementia / Alzheimer's

    Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

    Testing whether tightly lowering high blood pressure slows brain changes tied to Alzheimer’s

    📍 University of Texas Southwestern Medical Center · Dallas, TX · Get directions →

    The purpose of this study is to determine if intensive lowering of systolic blood pressure (SBP), using FDA approved medications (antihypertensive), reduces Alzheimer's Disease pathology (i.e., excessive brain amyloid and tau protein deposition) in older adults at high risk for memory decline or dementia.

    ✓ Study care freePhase 2Ages 60–85Learn more →
  • Asthma

    Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

    Comparing two asthma inhalers to see they work the same way

    📍 Hospital Británico de Buenos Aires_Site n. 032029 · Buenos Aires, · Get directions →

    This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an existing propellant. We want to make sure both versions of the inhaler work the same way for people with mild to moderate asthma.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Kidney disease

    Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

    Testing a new kidney tissue transplant to treat end-stage kidney disease

    📍 New York University Langone Health · New York, NY · Get directions →

    The purpose of this study is to evaluate the safety and efficacy of the GGTA1 KO Thymokidney in patients with end-stage renal disease (ESRD) who are either not eligible for conventional allogeneic kidney transplantation (Group 1) or are on an Organ Procurement and Transplantation Network (OPTN) kidney transplant waitlist, but are more likely to die or go untransplanted within 5 years than receive a kidney transplant (Group 2). The study consists of xenotransplantation followed by a 24-week Post-transplant Follow-up Period (Part A) to evaluate the efficacy and safety objectives followed by a Long-term Follow-up Period (Part B) to evaluate participant survival, GGTA1 KO Thymokidney survival, and screening for zoonotic infections.

    ✓ Study care freePhase 1Ages 40–70Learn more →
  • Obesity / overweightHigh blood pressureCOPD (chronic lung disease)

    Feasibility of Semaglutide in Advanced Lung Disease

    Testing whether semaglutide can be given safely to people with advanced lung disease

    📍 University of Pennsylvania Perelman School of Medicine · Philadelphia, PA · Get directions →

    The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with advanced lung disease. The main question\[s\] it aims to answer are: 1.

    ✓ Study care freePhase 1Ages 18–80Learn more →
  • Kidney disease

    Breakthrough - T1DM and Chronic Kidney Disease

    Testing an experimental treatment of Tegoprubart plus islet cells for diabetes and chronic kidney

    📍 The University of Chicago · Chicago, IL · Get directions →

    Single arm- subject treated with Tegoprubart and everolimus. The purpose of this research is to gather information on the safety and effectiveness of investigational regimen containing 2 experimental components: * An investigational drug called Tegoprubart and * Human pancreatic islet cells Both Tegoprubart and human pancreatic islet cells are considered investigational because they are not approved for use in the United States by the Food and Drug Administration (FDA).

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Kidney diseaseCrohn's / ulcerative colitis (IBD)

    Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

    Comparing patient preferences for skin injections vs IV for immune therapy in kidney disease or

    📍 UPMC Hillman Cancer Center · Pittsburgh, PA · Get directions →

    The study will evaluate patient and Health Care Professional- reported preference for Subcutaneous (SC) compared with IV nivolumab administration or similarly for SC compared with IV pembrolizumab.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Kidney disease

    REgulatory T Cell Therapy to Achieve Immunosuppression REduction

    Testing a cell therapy to lower the chance of kidney transplant rejection

    📍 Mayo Clinic in Arizona · Phoenix, AZ · +2 more US sites · Get directions →

    The goal of this multi-national, multi-center, open-label, randomized Phase 2 trial is to determine the safety and efficacy of administering expanded regulatory T cells (TRK-001) to prevent allograft rejection in living donor renal transplant recipients. Enrolled subjects will be randomized to one of 2 study arms: Arm 1 subjects will receive standard of care immunosuppression Arm 2 subjects will receive initial standard of care (SOC) immunosuppression and a single infusion of TRK-001.

    ✓ Study care freePhase 2Ages 18–65Learn more →
  • High blood pressureKidney disease

    Equol and Vascular Function in Women With Chronic Kidney Disease

    Testing whether equol affects blood vessel function in women with chronic kidney disease

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · Get directions →

    The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk.

    ✓ Study care freePhase 2Ages 50+WomenLearn more →
  • Asthma

    A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study

    Testing the long-term safety and effectiveness of an asthma pill in people who joined an earlier

    📍 Kymera Investigative Site · Tampa, FL · Get directions →

    This Phase 2b open-label, long-term extension study is designed to evaluate the long-term safety and efficacy of KT-621 in participants with asthma who were previously enrolled in the parent study (KT621-AS-202) of KT-621 for asthma. The main goals of this study are to investigate the long-term safety and tolerability of KT-621, the long-term efficacy of KT-621 at treating asthma, and how KT-621 behaves in the body long-term.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Kidney disease

    A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

    Testing a medicine given at fixed doses for high phosphate in adults on hemodialysis

    📍 R1 Therapeutics Clinical Trial Site · Huntsville, AL · +22 more US sites · Get directions →

    This study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receiving maintenance hemodialysis.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Obesity / overweightKidney disease

    Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

    Testing a 1-year weight-loss medicine to slow kidney cyst growth in adults with ADPKD

    📍 University of Colorado - Anschutz Medical Campus · Aurora, CO · Get directions →

    The proposed clinical trial aims to assess if a year of treatment with a glucagon-like peptide 1 receptor agonist, a medication approved for weight management that also improves the body's response to glucose and insulin, can slow kidney growth in adults with autosomal dominant polycystic kidney disease who are overweight or obese. The study will also evaluate changes in abdominal fat and kidney metabolism using cutting-edge images techniques.

    ✓ Study care freePhase 2Ages 18–65Learn more →
  • Asthma

    5HTP Regulation Of Asthma In Children

    Testing whether the supplement 5HTP improves asthma breathing in children

    📍 Indiana University · Indianapolis, IN · Get directions →

    The purpose of this study is to learn more about if taking a supplement called 5-hydroxytryptophan (5HTP) can improve breathing and anxiety symptoms related to asthma. To help learn more subjects will either be assigned to a group that is taking the supplement (5HTP) or a group that is taking a placebo.

    ✓ Study care freePhase 2Ages 8–18Learn more →
  • Kidney disease

    Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

    Testing orellanine in kidney cancer patients on chronic hemodialysis to see if it is safe and may

    📍 Stanford · Palo Alto, CA · +2 more US sites · Get directions →

    A phase I/II, open-label, study to determine the safety and preliminary efficacy of orellanine in patients with metastatic clear-cell or papillary renal carcinoma who have failed standard-of-care therapy. All participants must have end-stage kidney disease and be receiving stable chronic hemodialysis.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Asthma

    Viral Mucosal Reprogramming

    Studying how a nasal viral treatment affects genes in airway tissue in people with asthma

    📍 University of Texas Medical Branch · Galveston, TX · Get directions →

    This is a mechanistic, controlled, open-label, single-site study to evaluate the effects of RG-RV16 inoculation on airway mucosal gene expression and airway remodeling in 25 healthy controls (HC), in 25 allergic rhinitis subjects (AR) with cat dander allergy, and in 25 allergic asthmatic subjects (AA) with cat dander allergy. Three groups (HC, AR, and AA) will undergo screening to establish clinical history, will undergo pulmonary function testing (spirometry), and will have blood drawn for clinical characterization (IgE, , ImmunoCAP, CBC and differential), and for assessing the presence of existing neutralizing antibody against RV16.

    ✓ Study care freePhase 2Ages 18–60Learn more →
  • Kidney disease

    A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

    Comparing doses of a new medicine to see effects on kidney damage in chronic kidney disease

    📍 N America Res Inst - San Dimas · San Dimas, CA · +17 more US sites · Get directions →

    The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney function in participants with chronic kidney disease with or without type 2 diabetes, living with overweight or obesity.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Asthma

    Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma

    Testing an inhaled treatment to see how it affects late asthma symptoms after allergy exposure

    📍 Research Site 1 · Vancouver, British Columbia · Get directions →

    The purpose of this study is to evaluate the impact of inhaled ARO-RAGE on the late asthmatic response (LAR) following an inhaled allergen challenge in participants with mild atopic asthma.

    ✓ Study care freePhase 2Ages 18–65Learn more →
  • Kidney disease

    Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

    Testing medicines that lower ANGPTL3 in adults with diabetic kidney disease

    📍 Apogee Clinical Research, LLC · Huntsville, AL · +39 more US sites · Get directions →

    This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidney disease.

    ✓ Study care freePhase 2Ages 18–80Learn more →
  • Asthma

    A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

    Testing how two different inhaled doses affect lung function in children (ages 4–11) with asthma

    📍 Research Site · Bakersfield, CA · +10 more US sites · Get directions →

    The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

    ✓ Study care freePhase 2Ages 4–11Learn more →
  • Kidney disease

    Safety and Efficacy of Empagliflozin in Hemodialysis

    Testing whether empagliflozin is safe and effective for people starting hemodialysis

    📍 Brigham and Women's Hospital · Boston, MA · +1 more US site · Get directions →

    A 12-week, phase II, randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability, and preliminary efficacy of empagliflozin versus placebo among patients initiating hemodialysis (n=60) for the treatment of end-stage kidney disease.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Asthma

    Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

    Testing lung MRI images using special breathing gases in people with asthma

    📍 The Hospital for Sick Children · Toronto, Ontario · Get directions →

    Aim of this study is to evaluate image quality and reproducibility of Xenon-129 and Inert fluorinated (19F) gas Magnetic Resonance Imaging (MRI) and to evaluate changes in lung structure and function in participants with cystic fibrosis (CF) and asthma compared to healthy controls.

    ✓ Study care freePhase 2Ages 8+Learn more →
  • Kidney disease

    Neurovascular Transduction During Exercise in Chronic Kidney Disease

    Studying why people with chronic kidney disease have low exercise capacity and high blood pressure

    📍 Emory University Hospital Midtown · Atlanta, GA · +2 more US sites · Get directions →

    The purpose of this study is to find out why patients with chronic kidney disease (CKD) have poor exercise capacity and to explore what causes an increase in blood pressure during exercise (i.e. increased adrenaline levels, or decreased ability of blood vessels to dilate).

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Asthma

    Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

    Testing a medicine that blocks interleukin-5 for asthma caused by EGPA

    📍 National Jewish Health · Denver, CO · Get directions →

    Reslizumab is a type of medicine called a monoclonal antibody that is made in the research clinic; it works by blocking a specific protein in the body called interleukin-5. The study medicine, reslizumab, is not yet approved for doctors to treat patients with EGPA.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Kidney disease

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

    Testing Envarsus XR versus twice-daily tacrolimus in kidney transplant rejection and blood immune

    📍 Deepa Valvi · Lexington, KY · Get directions →

    This will be a single center, prospective, open-label, randomized, controlled trial comparing Envarsus XR® to twice-daily tacrolimus. The targeted population will be patients with end stage renal disease listed for primary solitary kidney transplant.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Obesity / overweightAsthma

    Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

    Testing a medicine to see how it affects asthma inflammation in obese adults

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · Get directions →

    The main purpose of this Phase 2 double blind, placebo controlled crossover clinical study is to demonstrate the efficacy and safety of CXA-10 in obese adult asthmatics. Obesity induces a chronic systemic inflammatory state characterized by impaired adipokine signaling, pro-inflammatory cytokine responses, inflammatory cell activation and enhanced generation of oxidative inflammatory mediators.

    ✓ Study care freePhase 2Ages 18–65Learn more →
  • Obesity / overweightAsthma

    Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes

    Testing whether adding L-citrulline helps people with obesity and late-onset asthma

    📍 Duke University (Asthma, Allergy and Airway Center) · Durham, NC · Get directions →

    Patients with obese late onset (after childhood) asthma can have lower FeNO levels, yet be highly symptomatic and poorly responsive to inhaled steroids. This is a common asthma phenotype, particularly among females.

    ✓ Study care freePhase 2Ages 18–65Learn more →
  • Type 2 diabetesKidney disease

    Uric Acid Lowering Trial in Youth Onset T2D

    Testing how lowering uric acid affects young people with type 2 diabetes and kidney disease

    📍 Children's Hospital Colorado · Aurora, CO · Get directions →

    Adolescents and young adults with youth-onset type 2 diabetes (T2D) are disproportionally impacted by hyperuricemia compared to non-diabetic peers and youth with type 1 diabetes (T1D). In fact, 50% of males with youth-onset T2D have serum uric acid (SUA) greater than 6.8 mg/dl.

    ✓ Study care freePhase 2Ages 18–25MenLearn more →
  • Kidney diseaseDepression

    Combination of Novel Therapies for CKD Comorbid Depression

    Testing whether treating major depression improves outcomes in people with chronic kidney disease

    📍 Stony Brook University Medical Center · Stony Brook, NY · +3 more US sites · Get directions →

    The overall goal of the study is to determine if treatment of a Major Depressive Disorder (MDD) improves the outcomes of patients with chronic kidney disease (CKD). We showed that MDD is present in 25% of CKD patients and independently associated with progression to End-Stage Kidney Disease, hospitalization, and death.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Kidney disease

    Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

    Testing a treatment for people with pulmonary hypertension and severe kidney problems, with or

    📍 Clinical Trial Site · San Francisco, CA · +3 more US sites · Get directions →

    The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.

    ✓ Study care freePhase 2Learn more →
  • Heart / cardiovascular diseaseHigh blood pressure

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

    Studying how vitamin C affects blood vessel function in obese adults with insulin resistance and

    📍 University of Kansas Medical Center · Kansas City, KS · Get directions →

    The main purpose of research is to examine and understanding the development of hypertension in obese adults with insulin resistance. Findings from our studies will identify unique mechanisms that can be targeted to limit increases in vascular dysfunction and reduce the excessively high prevalence of hypertension and risk for cardiovascular disease (CVD).

    ✓ Study care freePhase 1Ages 35–65Learn more →
  • Kidney disease

    Ferric Citrate and Chronic Kidney Disease in Children

    Testing whether ferric citrate changes a kidney hormone in children with CKD

    📍 University of California, Los Angeles · Los Angeles, CA · +17 more US sites · Get directions →

    We will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) in 160 pediatric patients (80 in each of the two arms) aged 6-18 years of either sex with chronic kidney disease (CKD) stages 3-4 and age-appropriate normal serum phosphate levels. Participants will be randomized to one of the two groups: 1) FC or 2) FC placebo.

    ✓ Study care freePhase 2Ages 6–18Learn more →
  • High blood pressureCOPD (chronic lung disease)

    Pulmonary Hypertension SOLAR

    Testing a noninvasive MRI pattern to study lung blood vessel changes in pulmonary hypertension

    📍 Duke University Medical Center · Durham, NC · Get directions →

    The main goal of this study is to develop a noninvasive signature for pulmonary vascular remodeling in Group 3 PH patients, using hyperpolarized 129Xe magnetic resonance imaging (129Xe MRI). Such a signature may identify Group 3 PH responders to PAH-specific therapies.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

    Testing timing of blood pressure medicines in people with obesity and high blood pressure

    📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →

    Obese individuals have a higher prevalence of nocturnal hypertension and non-dipping blood pressure (BP). These conditions are associated with an increased risk of cardiovascular (CV) events and death.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Kidney disease

    Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

    Testing sodium bicarbonate on muscle energy use in people with chronic kidney disease

    📍 University of California Davis Health · Sacramento, CA · +1 more US site · Get directions →

    Skeletal muscle metabolic health is critical for mobility and an underrecognized target of metabolic acidosis in chronic kidney disease. Impaired muscle mitochondrial metabolism underlies poor physical endurance increasing the risk of mobility disability.

    ✓ Study care freePhase 2Ages 21–85Learn more →
  • Kidney disease

    Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

    Testing the safety, drug levels, and effects of AT 1501 in kidney transplant patients

    📍 University of Cincinnati · Cincinnati, OH · Get directions →

    This study will evaluate the safety, PK, and efficacy of AT 1501 in patients undergoing kidney transplantation.

    ✓ Study care freePhase 1Ages 18–100Learn more →
  • Showing the first 60 of 69. Add filters or a location to narrow down.